Evaluation of MALDI-TOF MS for Identification of Species in the Candida parapsilosis Complex from Candidiasis Cases
- PMID: 35348720
- DOI: 10.1093/jalm/jfac005
Evaluation of MALDI-TOF MS for Identification of Species in the Candida parapsilosis Complex from Candidiasis Cases
Abstract
Background: Phenotypically identified Candida parapsilosis is actually a complex of 3 member species named Candida parapsilosis sensu stricto (CPSS), Candida orthopsilosis (CO), and Candida metapsilosis (CM), which can be identified only by molecular methods and automated methods such as MALDI-TOF mass spectrometry (MS). This study was undertaken to evaluate the VITEK MS, which uses the principle of MALDI-TOF MS for the identification of member species of C. parapsilosis complex (CPC).
Methods: In this cross-sectional study, 126 presumptively identified and stocked isolates of CPC were included. Definite identification to species level was done by VITEK MS and PCR as the gold standard method. Clinico-demographic characters and risk factors were analyzed. Antifungal susceptibility testing was performed for fluconazole and voriconazole.
Results: Twelve isolates were not identified as CPC either by VITEK MS or PCR and hence were excluded from the analysis. Out of 114 CPC isolates, 89 (78.1%), 18 (15.8%), and 7 (6.1%) isolates were identified as CPSS, CO, and CM, respectively, by VITEK MS. PCR identified 84 (79.2%), 15 (14.2%), and 7 (6.6%) isolates as CPSS, CO, and CM, respectively. However, PCR did not detect 8 isolates of CPSS detected by VITEK MS. VITEK MS showed 95.3% agreement in species identification and showed a kappa coefficient of 0.87, which is almost perfect agreement. Predominant isolations of all 3 species were from blood. Resistance was observed more in CPSS for both the azoles.
Conclusion: MALDI-TOF MS can be used as a rapid, reliable, cost-effective method to identify the species of CPC.
Keywords: Candida metapsilosis; Candida orthopsilosis; Candida parapsilosis sensu stricto; CM; CO; CPC; CPSS; MALDI-TOF MS; PCR.
© American Association for Clinical Chemistry 2022. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts, Candida orthopsilosis, and Candida metapsilosis: An Iranian Multicenter Study (2014-2019).Front Cell Infect Microbiol. 2019 Jul 30;9:264. doi: 10.3389/fcimb.2019.00264. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 31417877 Free PMC article.
-
Comparative in vitro activities of seven antifungal drugs against clinical isolates of Candida parapsilosis complex.J Mycol Med. 2020 Sep;30(3):100968. doi: 10.1016/j.mycmed.2020.100968. Epub 2020 Apr 4. J Mycol Med. 2020. PMID: 32386800
-
Species distribution and antifungal susceptibility among clinical isolates of Candida parapsilosis complex from India.Rev Iberoam Micol. 2018 Jul-Sep;35(3):147-150. doi: 10.1016/j.riam.2018.01.004. Epub 2018 Jul 8. Rev Iberoam Micol. 2018. PMID: 29997030
-
Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.J Med Microbiol. 2019 May;68(5):770-777. doi: 10.1099/jmm.0.000963. Epub 2019 Mar 29. J Med Microbiol. 2019. PMID: 30924763 Review.
-
Investigating Antifungal Susceptibility in Candida Species With MALDI-TOF MS-Based Assays.Front Cell Infect Microbiol. 2019 Feb 7;9:19. doi: 10.3389/fcimb.2019.00019. eCollection 2019. Front Cell Infect Microbiol. 2019. PMID: 30792970 Free PMC article. Review.
Cited by
-
Candida parapsilosis complex in the clinical setting.Nat Rev Microbiol. 2024 Jan;22(1):46-59. doi: 10.1038/s41579-023-00961-8. Epub 2023 Sep 6. Nat Rev Microbiol. 2024. PMID: 37674021 Review.
-
Candidemia in Brazilian neonatal intensive care units: risk factors, epidemiology, and antifungal resistance.Braz J Microbiol. 2023 Jun;54(2):817-825. doi: 10.1007/s42770-023-00943-1. Epub 2023 Mar 9. Braz J Microbiol. 2023. PMID: 36892755 Free PMC article.
-
Candida glabrata Empyema Thoracis-A Post-COVID-19 Complication.J Fungi (Basel). 2022 Aug 30;8(9):923. doi: 10.3390/jof8090923. J Fungi (Basel). 2022. PMID: 36135649 Free PMC article.
-
Candida parapsilosis and echinocandins: should the clinical laboratory drop anidulafungin Etest from the susceptibility testing panel?Antimicrob Agents Chemother. 2025 Aug 6;69(8):e0024125. doi: 10.1128/aac.00241-25. Epub 2025 Jul 1. Antimicrob Agents Chemother. 2025. PMID: 40590712 Free PMC article.
-
Clinical Characteristics of Candidemia Due to Candida parapsilosis with Serial Episodes: Insights from 5-Year Data Collection at a Tertiary Hospital in Korea.J Fungi (Basel). 2024 Sep 1;10(9):624. doi: 10.3390/jof10090624. J Fungi (Basel). 2024. PMID: 39330384 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical